0001209191-22-062125.txt : 20221220
0001209191-22-062125.hdr.sgml : 20221220
20221220132953
ACCESSION NUMBER: 0001209191-22-062125
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221216
FILED AS OF DATE: 20221220
DATE AS OF CHANGE: 20221220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RAMSAY DAVID A
CENTRAL INDEX KEY: 0001283292
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32157
FILM NUMBER: 221474064
MAIL ADDRESS:
STREET 1: HALOZYME THERAPEUTICS, INC.
STREET 2: 11588 SORRENTO VALLEY ROAD, #17
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Savara Inc
CENTRAL INDEX KEY: 0001160308
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841318182
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6836 BEE CAVE ROAD
STREET 2: BUILDING 3, SUITE 201
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 51285113796
MAIL ADDRESS:
STREET 1: 6836 BEE CAVE ROAD
STREET 2: BUILDING 3, SUITE 201
CITY: AUSTIN
STATE: TX
ZIP: 78746
FORMER COMPANY:
FORMER CONFORMED NAME: Mast Therapeutics, Inc.
DATE OF NAME CHANGE: 20130312
FORMER COMPANY:
FORMER CONFORMED NAME: ADVENTRX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030613
FORMER COMPANY:
FORMER CONFORMED NAME: BIOKEYS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20010928
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-12-16
0
0001160308
Savara Inc
SVRA
0001283292
RAMSAY DAVID A
6836 BEE CAVE ROAD
BUILDING III, SUITE 201
AUSTIN
TX
78746
1
0
0
0
Common Stock
2022-12-16
4
P
0
341
1.50
A
1946593
D
Common Stock
2022-12-19
4
P
0
40719
1.494
A
1987312
D
Common Stock
2022-12-20
4
P
0
13830
1.501
A
2001142
D
The price is a weighted average purchase price. The purchase prices ranged from $1.47 to $1.52. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
The price is a weighted average purchase price. The purchase prices ranged from $1.485 to $1.53. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
/s/ David Ramsay
2022-12-20